ProVerum Appoints Jesse Litwak as CFO to Strengthen Financial Leadership in Medtech

ProVerum Welcomes Jesse Litwak as New CFO

ProVerum Limited, a forward-thinking company specializing in medical devices aimed at addressing benign prostatic hyperplasia (BPH), has appointed Jesse Litwak as its Chief Financial Officer (CFO). This strategic move, announced on June 8, 2026, is aimed at strengthening the financial leadership team as ProVerum expands its operations and product offerings.

A Strategic Appointment

Jesse Litwak's extensive background in finance and leadership makes him a valuable addition to the ProVerum team. With 16 years of experience at Medtronic, one of the biggest names in the medtech industry, he previously served as Vice President of Finance and CFO for its Surgical business, a division with a remarkable $6 billion global revenue. His previous roles at Medtronic involved increasing responsibility in various finance-related functions, including business unit finance, financial planning and analysis (FPA), mergers and acquisitions (MA), and overall strategy.

Before his time at Medtronic, Litwak held finance positions at ATS Medical, a Minneapolis-based startup focused on heart valves, which was acquired by Medtronic in 2010, as well as Boston Scientific/Guidant. This diverse experience provides him with a unique insight into the challenges and opportunities within medtech, especially in scaling a business effectively.

Future Focus on BPH Treatments

The timing of Litwak's joining ProVerum is crucial, with the company poised to launch its FDA-approved ProVee technology aimed at enhancing the quality of life for millions suffering from BPH. The condition is a major concern affecting over 12 million men in the United States, characterized by symptoms such as frequent urination, especially at night, weak urine flow, and incomplete bladder emptying. Without intervention, these issues can progressively affect many aspects of daily living.

ProVerum’s CEO, Paul Bateman, expressed enthusiasm regarding Litwak’s appointment, emphasizing the importance of his extensive experience in both early-stage ventures and larger corporate settings. He noted, "Jesse joins the ProVerum team at an exciting time as we scale the business and bring our FDA-approved ProVee technology to help more patients living with BPH. His understanding of what is needed to thrive in the medtech sector and his leadership experience in finance, strategy, and MA will be vital to our continued growth."

About ProVerum Limited

Founded in Dublin, ProVerum Limited is dedicated to creating innovative, minimally invasive treatment solutions for conditions like BPH. The company is committed to advancing healthcare by providing effective options for patients, thereby enhancing their quality of life. As they prepare for further expansion and product implementation, the role of the CFO becomes increasingly critical in navigating the financial dynamics of growth in the medical technology space.

For those interested in learning more about ProVerum and its offerings, further details can be found on their website or through their social media platforms.

With this leadership enhancement, ProVerum is set to make significant strides in the medtech industry, delivering innovative solutions to a growing patient base as it continues its mission to transform treatment for BPH.